Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton's Tyrosine Kinase Inhibitor and Venetoclax
Blood(2021)
摘要
Background:
更多查看译文
关键词
chronic lymphocytic leukemia,tyrosine kinase inhibitor,covalent bruton
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要